PDI -- Table of Contents(2001, 21 [Suppl_3])

TABLE OF CONTENTS

QUICK SEARCH:

	Author:		Keyword(s):
Year:		Vol:		Page:

Receive this page by email each issue: [Sign up for eTOCs]

Contents: 2001, Volume 21, Issue Suppl_3 [Index by Author] Other Issues:

Articles

Clinical Trial

Find articles in this issue containing these words:
[Search ALL Issues]

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Articles

What happens to the peritoneal membrane in long-term peritoneal dialysis?: AS De Vriese, S Mortier, NH Lameire
Perit Dial Int 2001 21: S9–18. [PDF]

Molecular mechanisms of peritoneal permeability--research in growth factors: O Devuyst
Perit Dial Int 2001 21: S19–S23. [PDF]

The role of extracellular matrix in transperitoneal transport of water and solutes: MF Flessner
Perit Dial Int 2001 21: S24–S29. [Abstract] [PDF]

Aquaporins are unlikely to be affected in marked ultrafiltration failure: results from a computer simulation: B Rippe, J de Arteaga, D Venturoli
Perit Dial Int 2001 21: S30–S34. [PDF]

High glucose dialysis solutions increase synthesis of vascular endothelial growth factors by peritoneal vascular endothelial cells: MJ Seo, SJ Oh, SI Kim, KW Cho, I Jo, T Schaub, H Schilling, J Passlick-Deetjen, DC Han
Perit Dial Int 2001 21: S35–S40. [Abstract] [PDF]

Emodin ameliorates glucose-induced morphologic abnormalities and synthesis of transforming growth factor beta1 and fibronectin by human peritoneal mesothelial cells: S Yung, ZH Liu, KN Lai, LS Li, TM Chan
Perit Dial Int 2001 21: S41–S47. [Abstract] [PDF]

Aspirin protected the nitric oxide/cyclic GMP generating system in human peritoneum: MM Arriero, A Celdran, P Jimenez, A Garcia-Mendez, JC de la Pinta, F Manzarbeitia, L Munoz-Alameda, A Reyero, M Escribano, S Casado, A Lopez-Farre
Perit Dial Int 2001 21: S48–S53. [Abstract] [PDF]

Mesothelial paracrystalline inclusions in continuous ambulatory peritoneal dialysis patients: BB Stojimirovic, MM Obradovic, DP Trpinac, DD Milutinovic, DI Obradovic, VB Nesic
Perit Dial Int 2001 21: S54–S57. [Abstract] [PDF]

Diagnosis and management of encapsulating peritoneal sclerosis: CA Pollock
Perit Dial Int 2001 21: S61–S66. [Abstract] [PDF]

Encapsulating peritoneal sclerosis in Japan: prospective multicenter controlled study: H Kawanishi and Long-Term Peritoneal Dialysis Study Group
Perit Dial Int 2001 21: S67–S71. [Abstract] [PDF]

The greater incidence of encapsulating peritoneal sclerosis is not the result of overdiagnosis: M Nakayama
Perit Dial Int 2001 21: S72–S74. [PDF]

The problem of the high transporter: is survival decreased?: R Correa-Rotter and A Cueto-Manzano
Perit Dial Int 2001 21: S75–S79. [Abstract] [PDF]

Clinical outcome in continuous ambulatory peritoneal dialysis patients is not influenced by high peritoneal transport status: HC Park, SW Kang, KH Choi, SK Ha, DS Han, HY Lee
Perit Dial Int 2001 21: S80–S85. [Abstract] [PDF]

Peritoneal dialysis solutions: T Wang and B Lindholm
Perit Dial Int 2001 21: S89–S95. [Abstract] [PDF]

In vitro superiority of dual-chambered peritoneal dialysis solution with possible clinical benefits: J Passlick-Deetjen, M Pischetsrieder, J Witowski, TO Bender, A Jorres, C Lage
Perit Dial Int 2001 21: S96–101. [PDF]

Influence of neutral-pH dialysis solutions on the peritoneal membrane: a long-term investigation in rats: K Wieczorowska-Tobis, A Polubinska, TP Schaub, H Schilling, J Wisniewska, J Witowski, J Passlick-Deetjen, A Breborowicz
Perit Dial Int 2001 21: S108–S113. [Abstract] [PDF]

Glucose degradation products in peritoneal dialysis fluids: how they can be avoided: A Wieslander, T Linden, P Kjellstrand
Perit Dial Int 2001 21: S119–S124. [Abstract] [PDF]

A food chemist's view of advanced glycation end-products: T Henle
Perit Dial Int 2001 21: S125–S130.

Adequacy targets can be met in anuric patients by automated peritoneal dialysis: baseline data from EAPOS: EA Brown, SJ Davies, O Heimburger, F Meeus, G Mellotte, J Rosman, P Rutherford, M Van Bree, European Automated Peritoneal Dialysis Outcomes Study (EAPOS) Investigators
Perit Dial Int 2001 21: S133–S137. [Abstract]

Continuous flow peritoneal dialysis: C Ronco and R Dell'Aquila
Perit Dial Int 2001 21: S138–S143. [PDF]

Optimization of peritoneal dialysis prescription using computer models of peritoneal transport: B Haraldsson
Perit Dial Int 2001 21: S148–S151. [Abstract] [PDF]

Helicobacter pylori infection: a new cause of anorexia in peritoneal dialysis patients: A Aguilera, R Codoceo, MA Bajo, JJ Diez, G del Peso, M Pavone, J Ortiz, J Valdez, A Cirugeda, A Fernandez-Perpen, JA Sanchez-Tomero, R Selgas
Perit Dial Int 2001 21: S152–S156. [Abstract] [PDF]

Malnutrition, inflammation, and atherosclerosis in peritoneal dialysis patients: P Stenvinkel, SH Chung, O Heimburger, B Lindholm
Perit Dial Int 2001 21: S157–S162. [PDF]

The measurement of total body potassium in patients on peritoneal dialysis: G Woodrow, B Oldroyd, A Wright, WA Coward, JH Turney, AM Brownjohn, JG Truscott, MA Smith
Perit Dial Int 2001 21: S163–S167. [Abstract]

Is there a relationship between diet and nutrition status in continuous ambulatory peritoneal dialysis patients?: D Sutton, ST Talbot, JM Stevens
Perit Dial Int 2001 21: S168–S173. [PDF]

Should the DOQI adequacy guidelines be used to standardize peritoneal dialysis in children?: BA Warady
Perit Dial Int 2001 21: S174–S178. [Abstract] [PDF]

Is growth a valid outcome measure of dialysis clearance in children undergoing peritoneal dialysis?: V Chadha, DL Blowey, BA Warady
Perit Dial Int 2001 21: S179–S184. [Abstract] [PDF]

Should the DOQI adequacy guidelines be used to standardize the peritoneal dialysis dose in children?: AK Sharma
Perit Dial Int 2001 21: S185–S191. [PDF]

The DOQI pediatric nutritional guidelines--critical remarks: G Filler
Perit Dial Int 2001 21: S192–S194. [PDF]

Peritonitis in automated peritoneal dialysis: antibiotic therapy and pharmacokinetics: JA Diaz-Buxo, TL Crawford, GR Bailie
Perit Dial Int 2001 21: S197–S201. [PDF]

Tuberculous peritonitis in a cohort of continuous ambulatory peritoneal dialysis patients: G Abraham, M Mathews, L Sekar, A Srikanth, U Sekar, P Soundarajan
Perit Dial Int 2001 21: S202–S204. [Abstract] [PDF]

Implantation of presternal catheter using Moncrief technique: aiming for fewer catheter-related complications: M Kubota, M Kanazawa, Y Takahashi, H Io, N Ishiguro, Y Tomino
Perit Dial Int 2001 21: S205–S208. [Abstract] [PDF]

Lower malfunction rate with self-locating catheters: I Minguela, M Lanuza, R Ruiz de Gauna, R Rodado, S Alegria, AJ Andreu, MJ Gonzalez, B Rodriguez, JM Vitores, T Castellanos, C Martinez, B Aurrekoetxea, A Chena
Perit Dial Int 2001 21: S209–S212. [Abstract] [PDF]

Biofilms in peritoneal dialysis: MK Dasgupta and M Larabie
Perit Dial Int 2001 21: S213–S217. [Abstract] [PDF]

Peritoneal access in children: EA Harvey
Perit Dial Int 2001 21: S218–S222. [Abstract] [PDF]

Hyporesponsiveness to anemia therapy--what are we doing wrong?: IC MacDougall
Perit Dial Int 2001 21: S225–S230. [Abstract] [PDF]

Oral versus intravenous iron supplementation in peritoneal dialysis patients: DW Johnson, KA Herzig, R Gissane, SB Campbell, CM Hawley, NM Isbel
Perit Dial Int 2001 21: S231–S235. [Abstract] [PDF]

Aggressive therapy of congestive heart failure and associated chronic renal failure with medications and correction of anemia stops or slows the progression of both diseases: DS Silverberg, D Wexler, M Blum, D Sheps, D Schwartz, T Yachnin, R Baruch, J Tchebiner, A Zubkov, M Shaked, S Steinbruch, G Keren, A Iaina
Perit Dial Int 2001 21: S236–S240. [Abstract] [PDF]

Current issues in the management of secondary hyperparathyroidism and bone disease: SM Moe
Perit Dial Int 2001 21: S241–S246. [Abstract] [PDF]

Fragility fractures in dialysis and transplant patients. Is it osteoporosis, and how should it be treated?: AB Hodsman
Perit Dial Int 2001 21: S247–S255. [Abstract] [PDF]

Bisphosphonates in dialysis and transplantation patients: efficacy and safety issues: C Rodd
Perit Dial Int 2001 21: S256–S260. [Abstract] [PDF]

Building the evidence in peritoneal dialysis: use of randomized controlled trials, and observational and registry data: LM Moist
Perit Dial Int 2001 21: S263–S268. [Abstract] [PDF]

Integrated care: SJ Davies, W Van Biesen, J Nicholas, N Lameire
Perit Dial Int 2001 21: S269–S274. [Abstract] [PDF]

Factors governing cardiovascular risk in the patient with a failing renal transplant: C Rigatto and P Parfrey
Perit Dial Int 2001 21: S275–S279. [Abstract] [PDF]

Peritoneal dialysis in the patient with a failing renal allograft: SJ Davies
Perit Dial Int 2001 21: S280–S284. [Abstract] [PDF]

Undertreatment of cardiac risk factors in adolescents with renal failure: U Querfeld
Perit Dial Int 2001 21: S285–S289. [Abstract] [PDF]

Conception and pregnancy in peritoneal dialysis patients: S Hou
Perit Dial Int 2001 21: S290–S294. [PDF]

Gastroesophageal reflux and hyperacidity in chronic renal failure: CA Fallone and S Mayrand
Perit Dial Int 2001 21: S295–S299. [Abstract] [PDF]

Quality of life of elderly patients undergoing continuous ambulatory peritoneal dialysis: JB Trbojevic, VB Nesic, BB Stojimirovic
Perit Dial Int 2001 21: S300–S303. [Abstract] [PDF]

The cost barrier to peritoneal dialysis in the developing world--an Asian perspective: PK Li and KM Chow
Perit Dial Int 2001 21: S307–S313. [Abstract] [PDF]

The cost barrier to renal replacement therapy and peritoneal dialysis in the developing world: R Correa-Rotter
Perit Dial Int 2001 21: S314–S317. [Abstract] [PDF]

A retrospective survey of attitudes toward acceptance of peritoneal dialysis in Chinese end-stage renal failure patients in Hong Kong--from a cultural point of view: WK Lo, FK Li, CB Choy, SW Cheng, WL Chu, SY Ng, CY Lo, SL Lui
Perit Dial Int 2001 21: S318–S321. [Abstract] [PDF]

Vegetarianism in India: V Jayanthi
Perit Dial Int 2001 21: S322–S325. [PDF]

The challenges of treating children with renal failure in a developing country: KD Phadke and C Dinakar
Perit Dial Int 2001 21: S326–S329. [PDF]

In vivo peritoneal chamber: linking structure and transport function: MF Flessner
Perit Dial Int 2001 21: S335–S337. [Abstract] [PDF]

How can we standardize peritoneal thickness measurements in experimental studies in rats?: S Duman, S Sen, AI Gunal, G Asci, F Akcicek, A Basci
Perit Dial Int 2001 21: S338–S341. [Abstract] [PDF]

Morphologic aspects of chronic peritoneal dialysis in a rat model: K Wieczorowska-Tobis, R Brelinska, A Breborowicz, DG Oreopoulos
Perit Dial Int 2001 21: S342–S344. [Abstract] [PDF]

Increased peritoneal membrane permeability is associated with abnormal peritoneal surface layer: T Wang, HH Cheng, SM Liu, Y Wang, JL Wu, WX Peng, JH Zhong, B Lindholm
Perit Dial Int 2001 21: S345–S348. [Abstract] [PDF]

New animal models for encapsulating peritoneal sclerosis--role of acidic solution: H Nakamoto, H Imai, Y Ishida, Y Yamanouchi, T Inoue, H Okada, H Suzuki
Perit Dial Int 2001 21: S349–S353. [Abstract] [PDF]

Non anticoagulant effects of heparin: implications for animal models of peritoneal dialysis: AS De Vriese, S Mortier, NH Lameire
Perit Dial Int 2001 21: S354–S356. [Abstract] [PDF]

Effect in a rat model of heparinized peritoneal dialysis catheters on bacterial colonization and the healing of the exit site: YL Kim, S Cho, JC Kim, DK Cho, YJ Kim, O Larm, T Mathiesen, B Lindholm, J Bergstrom
Perit Dial Int 2001 21: S357–S358. [Abstract] [PDF]

The effect of icodextrin-based solutions on peritoneal transport in rats undergoing chronic peritoneal dialysis: K Pawlaczyk, E Garcia-Lopez, M Kuzlan-Pawlaczyk, O Heimburger, J Bergstrom, A Breborowicz, B Lindholm
Perit Dial Int 2001 21: S359–S361. [Abstract] [PDF]

Comparison of the biocompatibility of phosphate-buffered saline alone, phosphate-buffered saline supplemented with glucose, and dianeal 3.86%: K Wieczorowska-Tobis, A Styszynski, A Breborowicz, DG Oreopoulos
Perit Dial Int 2001 21: S362–S364. [Abstract] [PDF]

Replacement of glucose with N-acetylglucosamine in peritoneal dialysis fluid-experimental study in rats: A Breborowicz, M Pawlaczyk-Kuzlan, K Pawlaczyk, E Baum, P Tam, G Wu
Perit Dial Int 2001 21: S365–S367. [Abstract] [PDF]

A chronic inflammatory infusion model of peritoneal dialysis in rats: PJ Margetts, M Kolb, L Yu, CM Hoff, J Gauldie
Perit Dial Int 2001 21: S368–S372. [Abstract] [PDF]

Accumulation of omental mast cells during peritoneal dialysis: M Zareie, LH Hekking, BA Driesprong, PM ter Wee, RH Beelen, J van den Born
Perit Dial Int 2001 21: S373–S376. [Abstract] [PDF]

4th International Meeting on Animal Models in Peritoneal Dialysis--discussion forum: Perit Dial Int 2001 21: S377. [PDF]

Adequacy targets of peritoneal dialysis in the Asian population: PK Li and CC Szeto
Perit Dial Int 2001 21: S378–S383. [Abstract] [PDF]

Clinical Trial

Interleukin-6 levels decrease in effluent from patients dialyzed with bicarbonate/lactate-based peritoneal dialysis solutions: LA Cooker, P Luneburg, CJ Holmes, S Jones, N Topley, Bicarbonate/Lactate Study Group
Perit Dial Int 2001 21: S102–S107. [Abstract] [PDF]

Biologic significance of reduced levels of glucose degradation products: B Rippe and A Wieslander
Perit Dial Int 2001 21: S114–S118. [PDF]

Peritoneal dialysis fill volume: can the patient tell the difference?: KP Harris, AM Keogh, L Alderson
Perit Dial Int 2001 21: S144–S147. [Abstract] [PDF]

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

TABLE OF CONTENTS

Copyright © 2008 by Multimed Inc.